GlassScriptPhysician profile
Andrew Craig Margules
NPI 1043577091
$9,469.32
in general payments reported to CMS, 2019-2025
35 companies · $1,636 in 2025
The $1,636 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,387 · 2020: $324 · 2021: $695 · 2022: $853 · 2023: $1,737 · 2024: $1,837 · 2025: $1,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,155 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,154.65 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,425.04 | 2021-2025 | Interstim, Concertotm |
| Medtronic USA, INC. | $1,913.21 | 2019-2020 | |
| Dentsply Ih Ab | $808.72 | 2023-2025 | Lofric, Lofric |
| Astellas Pharma US INC | $565.49 | 2019-2023 | Myrbetriq, Xtandi |
| Teleflex LLC | $317.37 | 2021-2025 | Urolift |
| Abbvie INC. | $296.82 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $253.64 | 2023-2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $223.39 | 2019 | |
| Boston Scientific Corporation | $150.26 | 2019-2024 | Rezum Generator |
| Axonics, INC. | $149.83 | 2021-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $146.95 | 2025 | |
| Laborie Medical Technologies Corp. | $125.00 | 2019 | |
| Coloplast Corp | $115.25 | 2019-2024 | Speedicath |
| Endo Pharmaceuticals INC. | $113.75 | 2019 | |
| Urovant Sciences INC | $94.62 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $91.74 | 2021-2024 | Uribel Tabs |
| Dentsply Ih INC. | $80.31 | 2022 | |
| 180 Medical, INC. | $73.01 | 2021-2025 | |
| Janssen Biotech, INC. | $72.10 | 2021-2025 | Erleada |
| Convatec INC. | $42.52 | 2022-2023 | |
| Myriad Genetic Laboratories, INC. | $41.60 | 2022 | |
| Myovant Sciences INC. | $40.70 | 2021-2022 | |
| Pfizer INC. | $38.86 | 2025 | |
| Olympus America INC. | $37.18 | 2025 | Itind System |
| Avation Medical, INC. | $33.30 | 2025 | Vivally System |
| Dendreon Pharmaceuticals LLC | $31.82 | 2019 | |
| Allergan, INC. | $29.95 | 2020 | |
| Progenics Pharmaceuticals, INC. | $25.13 | 2025 | |
| Merck Sharp & Dohme LLC | $22.98 | 2022 | |
| Urogen Pharma, INC. | $22.93 | 2024 | |
| Accord Healthcare, INC. | $22.89 | 2022 | |
| Ambu INC. | $18.80 | 2021 | |
| Telix Pharmaceuticals | $18.77 | 2023 | Illuccix |
| Immunitybio, INC. | $14.86 | 2024 | |
| Valencia Technologies Corporation | $10.53 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Margules listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.